Author

Juliette Schlatter

University of Bern

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Adrian F. OchsenbeiniD· 1 shared Adrienne VancuraiD· 1 shared Álvaro AndradesiD· 1 shared Andrea Kobel· 1 shared Andrés LanzósiD· 1 shared Carlos Pulido-QuetglasiD· 1 shared Carsten RietheriD· 1 shared Dominik F. Meise· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adrian F. OchsenbeinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

Roberta Esposito, Taisia Polidori, Dominik F. Meise, Carlos Pulido-Quetglas, Panagiotis Chouvardas, Stefan Forster, Paulina Schaerer, Andrea Kobel, Juliette Schlatter, Erik Kerkhof, Michaela Roemmele, Emily S. Westemeier-Rice, Lina Zhu, Andrés Lanzós, Hugo Guillen-Ramirez, , Rory Johnson

The paper identifies 60 high-confidence oncogenic lncRNAs in NSCLC using CRISPR deletion screens and ASO validation, revealing therapeutic vulnerabilities.

Cell Genomics · Aug 22, 2022Peer-reviewedGenomics